"The investment from and partnership with Pappas Ventures has opened many doors for CardioDx at this critical stage for the company. Pappas has made key introductions for us in the private equity and corporate worlds, and they have connected us with the leadership of major health plans. CardioDx looks forward to a continuing collaboration with the team from Pappas Ventures."

David Levison
President and CEO of CardioDx

News

CardioDx Passes Trial, Determining When Chest Pain Is No Big Deal
Xconomy
November 15, 2011

Gene test may improve heart disease detection
msnbc.com
October 4, 2010

GE Healthcare forms strategic alliance with cardiovascular genomic diagnostic company, CardioDx
Download the PDF
May 13, 2010

CardioDx - Bringing molecular diagnostics into the cardiovascular arena
Download the PDF
March 1, 2010

CardioDx completes validation study of first-of-its-kind genomic test for coronary artery disease
Download the PDF
August 25, 2009